An Italian rescue helicopter of Italy has crashed high up on Monte Rosa, on the Swiss-Italian border. Miraculously, no one on board was injured. The helicopter was responding to an SOS when it cra ...

Monte Rosa Therapeutics bounded higher on Monday, as shares nearly doubled on a deal with Novartis to develop treatments for ...

“Last year was transformative for Monte Rosa, with significant validation of our capabilities to design and develop ‘only-in-class’ MGDs for previously undruggable targets across a broad ...

Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...

Wells Fargo analyst Derek Archila downgraded Monte Rosa Therapeutics (GLUE) to Equal Weight from Overweight with a price arget of $11, down from $14. The firm thinks the stock’s upside is ...

The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Monte Rosa Therapeutics stock rises as it announces a global licensing deal with Novartis to advance MRT-6160 for immune conditions. Vandana Singh Why Westport Fuel Systems Shares Are Trading ...

Upcoming Movies and TV shows Rotten Tomatoes Podcast Media News + More ...

So, the natural question for Monte Rosa Therapeutics (NASDAQ:GLUE) shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn as ...

https://www.tipranks.com/news/the-fly/intuitive-surgical-price-target-raised-to-622-from-561-at-btig Monte Rosa Therapeutics (GLUE) outlined anticipated 2025 ...